Professor of Medicine, Director, Hypertension Service, Vanderbilt University School of Medicine
Internal Medicine
Dr. Cheryl L. Laffer, MD
|
|
Give Review
Cheryl L. Laffer, MD works in the field of Internal Medicine. She went to medical school at University of Miami Miller School of Medicine. University of Miami Miller School of Medicine is ranked 45 in research and 0 in primary care medicine She has 1 awards "Fellow". Cheryl Laffer is a published doctor and has 32 publications published. The lastest was: 'The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patients.' She accepts Medicare payments and is registered with Medicare.gov.
Publications
- Diagnosis of pheochromocytoma on physical examination.
- A cautious view of the relationship between ambulatory blood pressure monitoring data and salt-sensitivity of blood pressure.
- Differential predictors of insulin resistance in nondiabetic salt-resistant and salt-sensitive subjects.
- Lack of Validation of a Same-Day Outpatient Protocol for Determination of Salt Sensitivity of Blood Pressure.
- Detrimental effects of dual ACEI-ARB therapy: is the (pro)renin receptor the culprit?
- Acute stroke: lower blood pressure looks better and better.
- Inflammation and therapy for hypertension.
- The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension.
- Effect of salt on isoprostanes in salt-sensitive essential hypertension.
- Is sodium restriction important to hypertension? The argument for.
- 20-HETE and circulating insulin in essential hypertension with obesity.
- 20-HETE and furosemide-induced natriuresis in salt-sensitive essential hypertension.
- Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic Acid in human salt-sensitive versus salt-resistant hypertension.
- Essential hypertension of Caribbean Hispanics: sodium, renin, and response to therapy.
- A role for single-pill triple therapy in hypertension.
- Mutating a gene for a potassium channel by hybrid dysgenesis: an approach to the cloning of the Shaker locus in Drosophila.
- Evidence for linkage between essential hypertension and a putative locus on human chromosome 17.
- The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patients.
- Regulation of growth of the adrenal gland in DOC-salt hypertension. Role of angiotensin II receptor subtypes.
- Cough induced by angiotensin-converting-enzyme inhibitors: Airway responses to inhalation of methacholine in patients who have essential hypertension.
- Predictors of the pressor response to the clinic visit in essential hypertensives with and without diabetes mellitus.
- Suboptimal outcome of management of metabolic cardiovascular risk factors in Hispanic patients with essential hypertension.
- Magnitude, reproducibility, and components of the pressor response to the clinic.
- Bayesian analysis supports use of ambulatory blood pressure monitors for screening.
- Endothelin-aldosterone interaction and proteinuria in low-renin hypertension.
- Participation of renal and circulating endothelin in salt-sensitive essential hypertension.
- Regulation of plasma endothelin by salt in salt-sensitive hypertension.
- Masked hypertension: a clinical entity or statistical gymnastics?
- The relationship between CYP4A11 and human hypertension.
- A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals.
- Three Angiotensin paradigms in one patient : etiology of hypertension, glomerular hemodynamics, and long-term glomerular protection.
Schools
University of Miami School of Medicine
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- Fellow
Education
-
Mount Sinai School of Medicine -
University of Miami Miller School of Medicine
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1699722371 | |
| NPPES Provider LastName | LAFFER | |
| NPPES Provider FirstName | CHERYL | |
| NPPES Provider ZIPCode | 372320001 | |
| NPPES Provider State | TN | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 696.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699722371 |
| Last Name Of The Provider | LAFFER |
| First Name Of The Provider | CHERYL |
| View All |
Similar Doctors
|
|
Dr. Neerav A. Desai, MD |
|
|
Dr. Mark M. Krakauer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger A. Hodge, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lewis B. Lefkowitz Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Geraldine Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dara L. Eckerle Mize, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Beverly Turner-Winbush, MD |
|
|
Dr. Edward G. Iglesia, MD |
|
|
Dr. Kenneth R. Johnsen, MD |
|
|
Dr. Kyle T. Mandsager, MD |
|
|
Dr. James Thomas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunil B. Kripalani, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Paul S. Smith, ED.D
This Doctor is OpenDoctor Recommended.
|
|
|
Mengistu Berie
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jayalakshmi Kuseladass, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Naim Sharifi
This Doctor is OpenDoctor Recommended.
|